| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.indswift.com | |
| Market Cap | 121.71 Cr. | |
| Enterprise Value(EV) | 1,097.46 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 5.50 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 4.09 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.22 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | -134.41 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | -0.17 | Calculated using Price: 22.47 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 5.42 Cr. | 54,164,653 Shares |
| FaceValue | 2 | |
| About Ind-Swift Ltd. | ||
| Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company. | ||
| 1 Day |
|
+4.99% |
| 1 Week |
|
-2.34% |
| 1 Month |
|
+22.67% |
| 3 Month |
|
+26.39% |
| 6 Month |
|
+47.03% |
| 1 Year |
|
+167.02% |
| 2 Year |
|
+74.63% |
| 5 Year |
|
+307.05% |
| 10 Year |
|
+228.13% |
| 5 years | 2016-03 | 2017-03 | 2018-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0 | 0 | 0 | 0 | 0 | |
| Return on Capital Employed (%) | -22.84 | -56.7 | -10.34 | 10.83 | 28.45 | |
| Return on Assets (%) | -18.95 | -42.37 | -8.46 | -3.21 | 4.07 |
| Particulars | 6 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | -245 | -616 | -663 | -720 | -705 | -713 | |
| Non Curr. Liab. | 679 | 672 | 680 | 634 | 418 | 424 | |
| Curr. Liab. | 621 | 608 | 598 | 718 | 936 | 928 | |
| Minority Int. | |||||||
| Equity & Liab. | 1,055 | 665 | 615 | 632 | 649 | 639 | |
| Non Curr. Assets | 433 | 458 | 429 | 389 | 376 | 373 | |
| Curr. Assets | 612 | 206 | 186 | 242 | 273 | 266 | |
| Misc. Exp. not W/O | 10 | ||||||
| Total Assets | 1,055 | 665 | 615 | 632 | 649 | 639 |
| Particulars | 6 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 304 | 263 | 270 | 398 | 411 | 473 | |
| Other Income | 13 | 14 | 15 | 24 | 12 | 18 | |
| Total Income | 317 | 277 | 284 | 421 | 423 | 491 | |
| Total Expenditure | -461 | -328 | -264 | -352 | -369 | -431 | |
| PBIDT | -144 | -52 | 21 | 69 | 54 | 60 | |
| Interest | -19 | -16 | -11 | -57 | -60 | -63 | |
| Depreciation | -36 | -36 | -35 | -32 | -29 | -27 | |
| Taxation | 0 | -1 | -1 | 0 | |||
| Exceptional Items | -260 | -28 | 1 | 61 | 61 | ||
| PAT | -200 | -364 | -54 | -20 | 26 | 30 | |
| Minority Interest | |||||||
| Share Associate | -14 | -8 | 4 | ||||
| Other Related Items | |||||||
| Consolidated Net Profit | -214 | -373 | -50 | -20 | 26 | 30 | |
| Adjusted EPS | -42 | -69 | -9 | -4 | 5 | 6 |
| Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -119 | -2 | 7 | 50 | 73 | |
| Cash Fr. Inv. | 10 | 4 | -6 | -18 | -29 | |
| Cash Fr. Finan. | 110 | -11 | -6 | -45 | -47 | |
| Net Change | 0 | -8 | -5 | -13 | -3 | |
| Cash & Cash Eqvt | 17 | 9 | 4 | 16 | 13 |
|
Wed, 10 Apr 2024
Clarification sought from Ind-Swift Ltd The Exchange has sought clarification from Ind-Swift Ltd on April 10 2024 with reference to Movement in Price. The reply is awaited. |
|
Wed, 10 Apr 2024
Clarification On Price Movement Clarification on price movement |
|
Wed, 10 Apr 2024
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Update on merger of the company with Ind Swift Laboratories Limited (Group Company) |
| Wed, 24 Apr 2024 |
Opening at Low
|
Closing Above Previous High
|
Opening at Low for 2 Days
|
High Increase in 1 Month
|
High Increase in 3 Months
|
